The largest database of trusted experimental protocols

Random primer 9

Manufactured by New England Biolabs
Sourced in Japan, United Kingdom

Random Primer 9 is a DNA primer designed for various molecular biology applications. It provides a random sequence that can be used to initiate DNA synthesis during techniques such as reverse transcription and random priming. The product is available in different concentrations to meet the needs of different experimental setups.

Automatically generated - may contain errors

10 protocols using random primer 9

1

RNA-seq Library Preparation for Pre-mRNA and mRNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Purified RNA (9 μg) was reverse transcribed using Random Primer 9 (NEB) and SuperScript II reverse transcriptase under MaP conditions as described previously (Smola et al., 2015 (link)). A no-reverse transcriptase control was also prepared. The resultant cDNA was purified over a G50 column (GE Healthcare) and subjected to second-strand synthesis (NEBNext Second Strand Synthesis Module). Supplementary file 4 lists PCR primers used for library generation. The cDNA was amplified with the NEB Q5 HotStart polymerase. Secondary PCR was performed to introduce TrueSeq barcodes (Smola et al., 2015 (link)). All samples were purified using the Ampure XP beads (Beckman Coulter), and quantification of the libraries was performed with Qubit dsDNA HS Assay kit (ThermoFisher Scientific). Final libraries were run on Agilent Bioanalyzer for quality check. TrueSeq libraries were then sequenced as paired-end 2 × 151 and 2 × 301 read multiplex runs on MiSeq platform (Illumina) for pre-mRNA and mature mRNA, respectively. Sequenced reads have been uploaded to the NCBI SRA database under BioProject ID PRJNA762079 for in-cell data and PRJNA812003 for cell-free data.
+ Open protocol
+ Expand
2

SARS-CoV-2 Viral RNA Extraction and Sequencing

Check if the same lab product or an alternative is used in the 5 most similar protocols
Viral RNA from clarified cell culture supernatant was isolated using TRIzol LS (Invitrogen) using a Direct-zol RNA Kit (Zymo Research) following manufacturers suggested protocol and quantified by NanoDrop (ThermoFisher Scientific). dsDNA was synthesized by random priming with Random Primer 9 (New England BioLabs) on 500-1000 ng of each isolate’s RNA and reverse transcribed using Super Script II (Sigma-Aldrich) to make cDNA followed by second strand synthesis using NEBNext Ultra II Non-Directional RNA Second Strand Synthesis Module (New England BioLabs) following the manufacturer’s suggested protocols. dsDNA was quantified using Qubit dsDNA HS Assay Kit (ThermoFisher Scientific). Libraries were prepared using Nextera XT DNA Library Preparation Kits (Illumina) and sequenced on a NovaSeq 6000 System (Illumina) with paired end reads (2 × 151). SARS-CoV-2 MA10 passage 2 reads were de novo assembled using CLC Genomics Workbench v12 (QIAGEN) to confirm initial viral sequence.
+ Open protocol
+ Expand
3

Quantitative Analysis of Breast Cancer Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
mRNA measurements were carried out as described previously39 (link). Briefly, the frozen breast cancer tissues were minced, placed into a tube containing beads, and homogenized in 9 volumes of lysis buffer with a Retsch MM300 (Qiagen, Hilden, Germany) mixer mill. After the removal of the beads, the samples were centrifuged at 12,000 xg for 20 min at 4 °C, and the supernatants were immediately used for total RNA extraction. Total RNA was isolated using the RNeasy mini kit (Qiagen) as described previously40 (link). Five hundred nanograms of total RNA were added to mixtures of 2.5 µM random primer 9 (NewEngland Biolabs, Beverly, MA), 500 µM dNTPs, 40 U RNase inhibitor (Takara Bio. Inc., Shiga, Japan) and 10 U M-MuLV reverse transcriptase (NewEngland Biolabs), and incubated at 42 °C for 60 min and then at 90 °C for 10 min. The mRNA expression values of ESR1, PGR, and HER2 were measured by a Quanti Tect SYBR Green PCR kit (Qiagen) with a Rotor-gene 6000 (Qiagen) at 95 °C for 15 min, followed by 45 cycles of 94 °C for 15 sec, 55 °C for 30 sec and 72 °C for 30 sec. The primers used for quantitative PCR (qPCR) are shown in Supplementary Table 10S. The calculated data were normalized to the values for the GAPDH used as a control gene.
+ Open protocol
+ Expand
4

Amplicon Sequencing of Mutant DNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Purified DNA underwent second-strand synthesis using Sequenase Version 2.0 (Thermo Fisher, UK) and random primer 9 (New England BioLabs, UK). Libraries were prepared from 1 ng of the resulting double-stranded DNA using the Nextera XT kit (Illumina, UK) and sequenced on the MiSeq platform with reagent kit v2 (500 cycles). After adapter removal and quality trimming using Trimmomatic [36 (link)], reads were aligned against the reference sequence (GenBank no. J02275) and the derived mutant sequences using Bowtie 2 [37 (link)].
+ Open protocol
+ Expand
5

RNA-seq Library Preparation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Purified RNA was reverse transcribed using Random Primer 9 (NEB) and SuperScript II reverse transcriptase under error prone conditions (Smola et al., 2015 (link)). The resultant cDNA was purified using G50 column (GE Healthcare) and subjected to second-strand synthesis (NEBNext Second Strand Synthesis Module). A standard Nextera DNA library protocol (Illumina) was used to fragment the cDNA and add sequencing barcodes. Samples were purified using Ampure XP beads (Beckman Coulter), and quantification of the libraries was performed with Qubit dsDNA HS Assay kit (ThermoFisher Scientific). Final libraries were run on Agilent Bioanalyzer for quality check. Gel purification (GeneJET, ThermoFisher Scientific) was performed as needed to remove primer dimer bands from libraries before sequencing. Libraries were sequenced as paired-end 2 × 151 read multiplex runs on MiSeq platform (Illumina). Sequenced reads have been uploaded to the NCBI SRA database under BioProject ID PRJNA762079 for in-cell data and PRJNA812003 for cell-free data.
+ Open protocol
+ Expand
6

Comprehensive Molecular Analysis of Tumor Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was isolated using TRIzol (Invitrogen) according to the manufacturer's protocol. One microgram of total RNA was reverse transcribed by M-MuLV reverse transcriptase and Random Primer 9 (NEB) following manufacturer's protocol. Semi-quantitative RT–PCR was performed using Advantage 2 PCR kit (Clontech) within the linear range of PCR cycles for each primer pair. Quantitative PCR was done using a 7500 Fast Real-Time PCR System (Applied Biosystems) with standard protocol. To determine p53 mutational status, RNA was extracted and RT–PCR was performed for each patient tumour sample. Full length p53 PCR product was gel purified and sequenced using standard procedures.
+ Open protocol
+ Expand
7

Quantification of lasA and gyrA Transcripts

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two hundred and fifty microliters of homogenized tissue were suspended in 1 ml of Trizol (ThermoFisher) and frozen at −80°C until extraction. RNA was extracted following manufacturer’s protocol. Extracted RNA was DNase treated with 10 units RQ-1 RNase free DNase (Promega) following manufacturer’s protocol. RNA was purified after DNase treatment using RNA Clean and Concentrator-25 (Zymo) and eluted in 30 μl of H2O, and quantified using a NanoDrop spectrophotometer. Five hundred nanograms of total RNA were used to generate cDNA using SuperScript II Reverse Transcriptase (ThermoFisher) and Random Primer 9 (NEB) following manufacturer’s protocol. Copy number of lasA and gyrA were quantified using iTaq Universal Sybr Green master mix (Bio-Rad) in 20 ul reaction volumes on a Roche LightCycler 96, using the following primer pairs: lasA_RT_5 5’-CCTGTTCCTCTACGGTCGCG-3’, lasA_RT_3 5’-GGTTGATGCTGTAGTAGCCG-3’, gyrA_5_RT 5’-GAAGCTGCTCTCCGAATACC-3’, gyrA_3_RT 5’-CAGTTCCTCACGGATCACCT-3’.
+ Open protocol
+ Expand
8

Zebrafish Embryo and Tissue RNA Extraction and cDNA Synthesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Each total RNA sample was extracted from 30-50 zebrafish embryos, single embryos or adult tissue samples by homogenizing them in 500μL Trizol reagent (Thermo Fisher Scientific, 15596026) using 1mL syringe and 21G needle and RNA was purified from lysates according to the Phasemaker tubes protocol (Thermo Fisher Scientific, A33248). For cDNA synthesis, a 4-μg aliquot of total RNA was treated with TurboDNAse using the TurboDNA-free kit (Thermo Fisher Scientific, AM1907). cDNA was produced by mixing 10μL of DNAsetreated RNA with 4μL of 2.5 mM dNTP and 2 μL of 80μM Random Primer 9 (NEB, S1254S) or 100μM oligo-dT(15-18) (Integrated DNA Technologies), heating at 70°C for 10 min and cooling on ice. Subsequently, 2μL of M-MuLV buffer (NEB, M0253S), 0.25μL of Protector RNAse Inhibitor (Roche, 03335399001), 0.25μL of M-MuLV reverse transcriptase (NEB, M0253S) and 1.6μL of water were added followed by incubation at 42°C for 1 hour and 10 min at 90°C. To amplify p53 cDNA fragments, we used p53cDNA primers (S1 Table ) to run the PCR on odT-based cDNA using Q5 High-Fidelity 2X Master Mix (NEB, M0492) with its standard program and annealing temperature of 64°C.
+ Open protocol
+ Expand
9

RNA-Seq Library Preparation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
First stand cDNA synthesis of treated RNA was carried out as previously described (22 (link)). Briefly, 29 μl of purified RNA was added to 100 ng Random Primer 9 (NEB), and 0.2 mM of each dNTP. This mix was then incubated at 65°C for 5 min before being transferred to ice, followed by addition of 50 mM Tris (pH 8.0), 75 mM KCl, 10 mM DTT, and 6 mM MnCl2 and 2 μl of SuperScript II Reverse Transcriptase (Invitrogen), supplemented with 20 U of murine RNase inhibitor (NEB) to achieve a final volume of 40 μl. The reaction was incubated at 25°C for 10 min, then 42°C for 3 h, then 70°C for 15 min. First strand cDNA was desalted using G50 columns (GE). The desalted product was then introduced into a second strand synthesis reaction. The cDNA second strand was generated using mRNA Non-Directional Second Strand Synthesis module (NEB). Double stranded DNA was then cleaned up using Ampure XP purification beads and eluted in 30 ul of water and quantified using a Qubit dsDNA HS Assay (Invitrogen). Double-stranded DNA was fragmented, repaired, and adaptor ligated for sequencing library preparation using the NEBNext® Ultra™ II DNA Library Prep Kit for Illumina®. Library quality was assessed using the High Sensitivity Bioanalyzer protocol (Agilent). Libraries were then loaded on an Illumina MiSeq at 10 pM and run at 300 cycles (150 × 2) or 600 cycles (300 × 2).
+ Open protocol
+ Expand
10

ADAM17 mRNA Expression Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
BMDMs were isolated as described above and differentiated for 7 days, at which point their RNA was isolated using the RNeasy mini kit from Qiagen.
Total RNA was reverse-transcribed using RNasin Plus (Promega), 2.5 mM dNTPs, Random Primer 9, and M-MuLV Reverse Transcriptase from NEB. ADAM17 oligonucleotides were purchased from Eurofins Genomics using previously described sequences (72 (link)), ADAM17 Forward 5’-GATGCTGAAGATGACACTGTG-3’ (A17 exon 14); ADAM17 Reverse 5’- GAGTTGTCAGTGTCAACGC-3’ (ADAM17 exon 14–15). GAPDH oligonucleotides were purchased from Qiagen. ADAM17 mRNA in wild-type and Adam17Δcyto tissues was quantified via RT-qPCR using SYBR Green Reagent and an ABI PRISM 7900HT cycler (both from Applied Biosystems, Thermo Fisher Scientific). GAPDH was used as a housekeeping control. Three independent experiments were performed with duplicate or triplicate samples for each experiment.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!